Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis
Clinical trial NCT00037687 · TERMINATED
Trial details
- NCT number
- NCT00037687
- Sponsor
- ICOS Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
- Enrollment
- 2500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.